Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Transthyretin discovery may halt progression of Alzheimer's

Transthyretin discovery may halt progression of Alzheimer's

Studies of human genetic variation have found strong evidence for the action of natural selection

Studies of human genetic variation have found strong evidence for the action of natural selection

More than one billion people will be over 60 years old by 2025

More than one billion people will be over 60 years old by 2025

Drinking alcohol regularly in your 40's increases risk of mild cognitive impairment

Drinking alcohol regularly in your 40's increases risk of mild cognitive impairment

Omega-3 supplement may help protect against Alzheimer's

Omega-3 supplement may help protect against Alzheimer's

Scientists discover breakthrough method to treat neuronal diseases

Scientists discover breakthrough method to treat neuronal diseases

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

Two new findings in the field of primary prevention for dementia and Alzheimer’s disease

First study of the emotional turmoil caregivers experience during the transition of their loved one from home to care facilities

First study of the emotional turmoil caregivers experience during the transition of their loved one from home to care facilities

Mission to uncover the genetic make-up of Britain

Mission to uncover the genetic make-up of Britain

Clearing toxins in the brains of Alzheimer's patients can stave off future reductions in cognitive abilities

Clearing toxins in the brains of Alzheimer's patients can stave off future reductions in cognitive abilities

Study finds no link between dental amalgam fillings containing mercury and disease

Study finds no link between dental amalgam fillings containing mercury and disease

Effectiveness of gingko to treat early dementia

Effectiveness of gingko to treat early dementia

People with type 2 diabetes could benefit from atorvastatin

People with type 2 diabetes could benefit from atorvastatin

Increased dementia risk after stroke

Increased dementia risk after stroke

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Authors redefine aging as any change in an organism over time

Authors redefine aging as any change in an organism over time

Zinc plays a crucial role in blindness

Zinc plays a crucial role in blindness

Public scandal - People with Alzheimer’s disease being denied essential drug treatments

Public scandal - People with Alzheimer’s disease being denied essential drug treatments

The prion appears to function as an evolutionary stepping stone

The prion appears to function as an evolutionary stepping stone

Study on RNAi technology targeting neurodegenerative diseases

Study on RNAi technology targeting neurodegenerative diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.